Skip to main content
Fig. 4 | Diabetology & Metabolic Syndrome

Fig. 4

From: Targeting hepatic sulfane sulfur/hydrogen sulfide signaling pathway with α-lipoic acid to prevent diabetes-induced liver injury via upregulating hepatic CSE/3-MST expression

Fig. 4

Inflammation and antioxidant status. A Plasma IL-1β B plasma IL-6, C plasma TNF-α, D hepatic IL-β, E hepatic IL-6, F hepatic TNF-α, G plasma MDA, H plasma GSH, I plasma SOD, J hepatic MDA, K hepatic GSH and L hepatic SOD. HC = Healthy control; T2DM = Untreated diabetic control; T2DM + ALA = Diabetic rats treated with alpha-lipoic acid; DT2M + PPG = Diabetic rats treated with propargylglycine

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us